Name: Keith D. Barlow

Email address: kbarlow@wfubmc.edu

Education:

PhD, Cell Biology (Georgetown University)
BA, Biochemistry and Molecular Biology (Clark University).

Advisor/Lab: Dr. Isabelle Berquin, Dr. Darren Seals.

Current research:  The role of Tks 5 adaptor protein and podosome formation in the modulation of mural cell and endothelial cell interactions in tumor angiogenesis.

Publications:

1.    Li L.Y., Barlow K.D., Metheny-Barlow L.J.  Angiopoietins and Tie2 in Health and Disease.  Ped. Endocrin. Rev. (2005) 3:399-408.

2.    Hardwick M., Cavalli L.R., Barlow K.D., Haddad B.R., Papadopoulos V. Peripheral-type benzodiazepine receptor (PBR) gene amplification in MDA-MB-231 aggressive breast cancer cells.  Cancer Genet Cytogenet. (2002) 139(1):48-51.

3.    Olivera A., Barlow K.D., Spiegel S.  Assaying sphingosine kinase activity.  Methods Enzymol. (2000) 311:215-23.

4.    Lee D.C., Barlow K.D., Gaido K.W. The actions of 2,3,7,8-tetrachlorodibenzo-p-dioxin on transforming growth factor-beta2 promoter activity are localized to the TATA box binding region and controlled through a tyrosine kinase-dependent pathway. Toxicol Appl Pharmacol. (1996) 137(1):90-9.

5.    Hattis D. and Barlow K.  Human interindividual variability in cancer risks - Technical and management challenges.  Hum Ecol Risk Assess (1996) 2 (1): 194-220.

Honors and Awards:

1.    Fellow, NIH/NCI T32 CA-079448 Training Program in Cancer Biology.  Frank M. Torti, P.I.  Wake Forest University Baptist Medical Center.

2.    DOD Breast Cancer Pre-doctoral Fellowship Grant. Georgetown University.

3.    Graduate Fellowship. Georgetown University.

4.    The Graduate Alumni Fellowship. University of Rochester.

5.    American Chemical Society Undergraduate Award in Analytical Chemistry.  Appalachian State University .